2 11 40 3d 3d 40 8 16 35 43 2b8 21 1a e 83 Juan pablo Ospina botero | Department of Neurology | Perelman School of Medicine at the University of Pennsylvania 62 4d 65 48 48 54 4e 52 5f 41 43 52 5b 7e 7a 88 59 55 4e 5f 57 4b 10 13 58 94 88 1e9 9 10e 3c 1f
a
11 12
1a 8
b
48 8
12
1f 12
1a
20
49 16
19
1b
89 faculty photo 35

Juan Pablo Ospina Botero

4e
Assistant Professor of Clinical Neurology
7 60
Department: Neurology
4 1 b
1d
46 Contact information
64
3400 Civic Center Boulevard
Philadelphia, PA 19104
26
35
f
4 3 3 3 2 4 b 1f
13 Education:
21 7 MD c
31 Universidad de los Andes, 2017.
c
3 3 21
1f Post-Graduate Training
24 33 Postdoctoral Research Fellow, Emory University 1b , 2017-2017.
24 5a Postdoctoral Research Fellow, Massachusetts General Hospital, 2018-2019.
24 76 Intern for Internal Medicine, University of Chicago/ Northshore University Health System, 2019-2020.
24 47 Neurology Resident, University of Chicago, 2020-2023.
24 4d Chief Resident, University of Chicago Neurology, 2022-2023.
24 7b Neuro-Oncology Fellow, Massachusetts General/ Brigham & Women's/ Dana-Farber Cancer Institute, 2023-2025.
c
3 25
17 Certifications
28 71 Program in Clinical Effectiveness, Harvard T.H. Chan School of Public Health, Boston, MA, 2024.
c
3 8d Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
2b 29
23

Selected Publications

208 Lanman TA, Youssef G, Huang R, Rahman R, DeSalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN: Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes 63 Neurooncol Adv 7(1): vdae227, Dec 2024 Notes: doi: 10.1093/noajnl/vdae227.

ea Ospina JP, Wen PY: Medical and neurologic management of brain tumor patients. Curr Opin Neurol 37(6): 657-665, Dec 2024 Notes: DOI: 10.1097/WCO.0000000000001315.

f6 Fortunato J, Ospina JP, Park DM: Chordoma. Neuro-Oncology. MedLink Neurology. San Diego: MedLink LLC, Nov 2024 Notes: https://www.medlink.com/articles/chordoma. Contributor.

12e Ospina JP, Viera M, Wetzel E, Cahill D, Gerstner ER, Miller JJ: Impact of resection at time of first recurrence in WHO Grade 2 IDH-mutant gliomas. Society for NeuroOncology Annual Meeting 2024 Nov 2024 Notes: Poster Presentation.

119 Ospina JP, Boss S, Javed A: Tractrography for Evaluation of Clinical Weakness in a Patient with Pilocytic Astrocytoma. Chicago, IL Jun 2023 Notes: Poster presented at Arnason Symposium, University of Chicago.

13c Duque L, Ospina JP, Savica R, Philbrick K, Port JD, Singh B: Characterization of Brain FDGPET Findings in Patients with Catatonia: A Case Series. Boston, MA Mar 2023 Notes: Poster presented at the American Neuropsychiatric Association Meeting.

5a Ospina, JP, Park, DM: Craniopharyngioma a5 Neuro-Oncology, MedLink Neurology. San Diego: MedLink LLC, Feb 20220 Notes: https://www.medlink.com/articles/craniopharyngioma. Contributor.

14e Duque L, Ospina JP, Philbrick K: Manic Episode as a Manifestation of Recurrent Primary Central Nervous System Lymphoma with Intravascular Involvement. Atlanta, GA Oct 2022 Notes: Poster presented at the Academy of Consultation-Liaison Psychiatry Annual Meeting.

123 Duque L, Ospina JP, Philbrick K, Singh B: Functional Neuroimaging in Patients with Catatonia: A Systematic Review. New Orleans, LA May 2022 Notes: Poster presented at the American Psychiatry Association Annual Meeting.

114 Duque L, Ospina JP, Singh B: Mixed Affective Episode as Initial Manifestation of Glioblastoma Multiforme. Cartagena, Colombia Feb 2022 Notes: Poster presented at the World Psychiatry Association – Latin America Regional 1d Congress.

2c
7 1d
2c back to top
26 Last updated: 03/17/2025
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 8
8
8
8
9
a 8
2c 30 9 7 0